MARKET

SRDX

SRDX

Surmodics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

54.18
+0.68
+1.27%
After Hours: 54.18 0 0.00% 16:00 03/03 EST
OPEN
53.73
PREV CLOSE
53.50
HIGH
54.50
LOW
53.14
VOLUME
40.34K
TURNOVER
--
52 WEEK HIGH
54.92
52 WEEK LOW
22.06
MARKET CAP
745.28M
P/E (TTM)
1175.27
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Insider Trends: Insider at SurModics Acquires Stock Via Conversion of Option/Derivative Security Sells Portion to Pay Tax, Buy Trend Intact
MT Newswires · 8h ago
Surmodics Inc Up 29.1% Since SmarTrend Uptrend Call (SRDX)
SmarTrend identified an Uptrend for Surmodics Inc (NASDAQ:SRDX) on December 4th, 2020 at $39.78. In approximately 3 months, Surmodics Inc has returned 29.13% as of today's recent price of $51.36.
Comtex SmarTrend(R) · 5d ago
Medical Device Coating Market Size, Share, Industry Growth, Price, Report 2020-2027
Japan, Japan, Thu, 25 Feb 2021 02:20:46 / Comserve Inc. / -- Competitive Analysis: SurModics Inc., Sono-Tek Corp, DSM, Hydromer, Inc., Biocoat, Inc.,...
Comserve · 6d ago
Vascular Stent Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025
Feb 22, 2021 (Heraldkeepers) -- The Global Vascular Stent Market is segmented on the lines of its material type and regional. Based on material type...
Heraldkeepers · 02/22 10:55
Insider Trends: SurModics Insider Sale Scaling Back 90-Day Buy Trend
MT Newswires · 02/18 16:51
How to trade Surmodics $SRDX With Risk Controls
Price matters most to making money in the market. Celebrating 20 years, Stock Traders Daily provides the tools that help you develop investment strategies,...
Stock Traders Daily · 02/12 02:20
The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Feb. 11)
Benzinga · 02/11 12:26
Surmodics (SRDX) Q1 Earnings Beat Estimates, Revenues Miss
Zacks.com · 02/10 16:31
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of SRDX. Analyze the recent business situations of Surmodics through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average SRDX stock price target is 67.50 with a high estimate of 76.00 and a low estimate of 61.00.
EPS
Institutional Holdings
Institutions: 216
Institutional Holdings: 12.60M
% Owned: 91.63%
Shares Outstanding: 13.76M
TypeInstitutionsShares
Increased
42
246.90K
New
25
65.31K
Decreased
53
287.18K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-2.37%
Healthcare Equipment & Supplies
-2.63%
Key Executives
Non-Executive Chairman/Independent Director
Susan Knight
Chief Executive Officer/President/Director
Gary Maharaj
Chief Financial Officer/Senior Vice President - Finance
Timothy Arens
Senior Vice President/Chief Marketing Officer
Teri Sides
Senior Vice President/General Counsel/Secretary
Gordon Weber
Senior Vice President/General Manager
Joseph Stich
Senior Vice President
Charles Olson
Vice President
Nusrath Sultana
Independent Director
Jose Bedoya
Independent Director
David Dantzker
Independent Director
Lisa Heine
Independent Director
Ronald Kalich
  • Dividends
  • Splits
  • Insider Activity
No Data
  • All
  • Financials
  • Insiders
More
About SRDX
Surmodics, Inc. is a provider of medical device and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company's Medical Device segment consists of surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices; international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device. The Company's In Vitro Diagnostics segment manufactures or sells components for in vitro diagnostic immunoassay and molecular tests. The In Vitro Diagnostics segment manufactures and sells surface coatings to the diagnostic, biomedical research and life science markets. In Vitro Diagnostics segment offers protein stabilization reagents, substrates, antigens and surface coatings.

Webull offers kinds of SurModics, Inc. stock information, including NASDAQ:SRDX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRDX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SRDX stock methods without spending real money on the virtual paper trading platform.